The role of local estrogen therapy in the management of pelvic floor disorders

被引:22
作者
Tzur, T. [1 ]
Yohai, D. [1 ]
Weintraub, A. Y. [1 ]
机构
[1] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Soroka Univ Med Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
关键词
pelvic floor disorders; menopause; Estrogen deficiency; local estrogen therapy; LOWER URINARY-TRACT; LOW-DOSE ESTRADIOL; CONJUGATED EQUINE ESTROGEN; 10; MU-G; POSTMENOPAUSAL WOMEN; VAGINAL ATROPHY; OVERACTIVE BLADDER; GENITOURINARY SYMPTOMS; CONTINENCE SOCIETY; SEXUAL DYSFUNCTION;
D O I
10.3109/13697137.2015.1132199
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Pelvic floor disorders are common and bothersome problems that include a variety of conditions. These conditions greatly affect the performance of daily activities and social function such as work, traveling, physical exercise, sleep and sexual function. Aging is a well-known factor affecting the pelvic floor and lower urinary tract anatomy and function. It is clear that the pelvic organs and their surrounding muscular and connective tissue support are estrogen-responsive. Treatment of pelvic floor disorders requires significant health-care resources and their impact is likely to increase in the near future. This literature review aims to provide an overview of both research and clinical aspects of the pathophysiology of urogenital estrogen deficiency and the role of local estrogen therapy as part of the management strategy of different pelvic floor disorders. The safety and risk concerns regarding the use of local estrogen therapy are addressed as well.
引用
收藏
页码:162 / 171
页数:10
相关论文
共 98 条
[1]   The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society (Reprinted from Neurourology and Urodynamics, vol 21, pg 167-178, 2002) [J].
Abrams, P ;
Cardozo, L ;
Fall, M ;
Griffiths, D ;
Rosier, P ;
Ulmsten, U ;
Van Kerrebroeck, P ;
Victor, A ;
Wein, A .
UROLOGY, 2003, 61 (01) :37-49
[2]   Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview [J].
Al-Baghdadi, O. ;
Ewies, A. A. A. .
CLIMACTERIC, 2009, 12 (02) :91-105
[3]   Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial [J].
Anderson, Garnet L. ;
Chlebowski, Rowan T. ;
Aragaki, Aaron K. ;
Kuller, Lewis H. ;
Manson, JoAnn E. ;
Gass, Margery ;
Bluhm, Elizabeth ;
Connelly, Stephanie ;
Hubbell, F. Allan ;
Lane, Dorothy ;
Martin, Lisa ;
Ockene, Judith ;
Rohan, Thomas ;
Schenken, Robert ;
Wactawski-Wende, Jean .
LANCET ONCOLOGY, 2012, 13 (05) :476-486
[4]   Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally [J].
Bachmann, Gloria ;
Bouchard, Celine ;
Hoppe, Diana ;
Ranganath, Radhika ;
Altomare, Corrado ;
Vieweg, Alberta ;
Graepel, Jay ;
Helzner, Eileen .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (04) :719-727
[5]   The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society [J].
Bachmann, Gloria A. ;
Johnston, Shawna L. ;
Kessel, Bruce ;
Knobf, M. Tish ;
Stewart, Elizabeth G. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (03) :357-371
[6]   ESTROGEN-INDUCED CHANGES IN MUSCARINIC RECEPTOR DENSITY AND CONTRACTILE RESPONSES IN THE FEMALE RABBIT URINARY-BLADDER [J].
BATRA, S ;
ANDERSSON, KE .
ACTA PHYSIOLOGICA SCANDINAVICA, 1989, 137 (01) :135-141
[7]  
Bernstein IT, 1997, NEUROUROL URODYNAM, V16, P237, DOI 10.1002/(SICI)1520-6777(1997)16:4<237::AID-NAU2>3.0.CO
[8]  
2-F
[9]   A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder [J].
Cardozo, L ;
Lose, G ;
McClish, D ;
Versi, E .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (10) :892-897
[10]  
Cardozo L D, 2001, J Obstet Gynaecol, V21, P383